Abstract
Bacterial virulence factors are attractive targets for the development of therapeutics. Type IV pili, which are associated with a remarkable array of properties including motility, the interaction between bacteria and attachment to biotic and abiotic surfaces, represent particularly appealing virulence factor targets. Type IV pili are present in numerous bacterial species and are critical for their pathogenesis. In this study, we report that trifluoperazine and related phenothiazines block functions associated with Type IV pili in different bacterial pathogens, by affecting piliation within minutes. Using Neisseria meningitidis as a paradigm of Gram-negative bacterial pathogens that require Type IV pili for pathogenesis, we show that piliation is sensitive to altered activity of the Na+ pumping NADH–ubiquinone oxidoreductase (Na+−NQR) complex and that these compounds probably altered the establishment of the sodium gradient. In vivo, these compounds exert a strong protective effect. They reduce meningococcal colonization of the human vessels and prevent subsequent vascular dysfunctions, intravascular coagulation and overwhelming inflammation, the hallmarks of invasive meningococcal infections. Finally, they reduce lethality. This work provides a proof of concept that compounds with activity against bacterial Type IV pili could beneficially participate in the treatment of infections caused by Type IV pilus-expressing bacteria.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 digital issues and online access to articles
$119.00 per year
only $9.92 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Data availability
Data supporting the findings of this study are available within the paper and the Supplementary Information. The sequences of the SNP variants resistant to the action of phenothiazines are available at NCBI’s BioProject database under accession number PRJNA481885.
References
Pelicic, V. Type IV pili: e pluribus unum? Mol. Microbiol. 68, 827–837 (2008).
Berry, J. L. & Pelicic, V. Exceptionally widespread nanomachines composed of Type IV pilins: the prokaryotic Swiss Army knives. FEMS Microbiol. Rev. 39, 134–154 (2015).
Craig, L. & Li, J. Type IV pili: paradoxes in form and function. Curr. Opin. Struct. Biol. 18, 267–277 (2008).
Kolappan, S. et al. Structure of the Neisseria meningitidis Type IV pilus. Nat. Commun. 7, 13015 (2016).
Helaine, S. et al. PilX, a pilus-associated protein essential for bacterial aggregation, is a key to pilus-facilitated attachment of Neisseria meningitidis to human cells. Mol. Microbiol. 55, 65–77 (2005).
Mikaty, G. et al. Extracellular bacterial pathogen induces host cell surface reorganization to resist shear stress. PLoS Pathog. 5, e1000314 (2009).
Brown, D. R., Helaine, S., Carbonnelle, E. & Pelicic, V. Systematic functional analysis reveals that a set of seven genes is involved in fine-tuning of the multiple functions mediated by Type IV pili in Neisseria meningitidis. Infect. Immun. 78, 3053–3063 (2010).
Stephens, D. S., Greenwood, B. & Brandtzaeg, P. Epidemic meningitis, meningococcaemia, and Neisseria meningitidis. Lancet 369, 2196–2210 (2007).
Coureuil, M. et al. Meningococcus hijacks a β2-adrenoceptor/β-arrestin pathway to cross brain microvasculature endothelium. Cell 143, 1149–1160 (2010).
Bernard, S. C. et al. Pathogenic Neisseria meningitidis utilizes CD147 for vascular colonization. Nat. Med. 20, 725–731 (2014).
Maissa, N. et al. Strength of Neisseria meningitidis binding to endothelial cells requires highly-ordered CD147/β2-adrenoceptor clusters assembled by alpha-actinin-4. Nat. Commun. 8, 15764 (2017).
Coureuil, M. et al. Meningococcal Type IV pili recruit the polarity complex to cross the brain endothelium. Science 325, 83–87 (2009).
Coureuil, M., Lecuyer, H., Bourdoulous, S. & Nassif, X. A journey into the brain: insight into how bacterial pathogens cross blood–brain barriers. Nat. Rev. Microbiol. 15, 149–159 (2017).
Sokolova, O. et al. Interaction of Neisseria meningitidis with human brain microvascular endothelial cells: role of MAP- and tyrosine kinases in invasion and inflammatory cytokine release. Cell. Microbiol. 6, 1153–1166 (2004).
Melican, K., Michea Veloso, P., Martin, T., Bruneval, P. & Dumenil, G. Adhesion of Neisseria meningitidis to dermal vessels leads to local vascular damage and purpura in a humanized mouse model. PLoS Pathog. 9, e1003139 (2013).
Girardin, E., Grau, G. E., Dayer, J. M., Roux-Lombard, P. & Lambert, P. H. Tumor necrosis factor and interleukin-1 in the serum of children with severe infectious purpura. N. Engl. J. Med. 319, 397–400 (1988).
Waage, A., Brandtzaeg, P., Halstensen, A., Kierulf, P. & Espevik, T. The complex pattern of cytokines in serum from patients with meningococcal septic shock. Association between interleukin 6, interleukin 1, and fatal outcome. J. Exp. Med. 169, 333–338 (1989).
Join-Lambert, O. et al. Meningococcal interaction to microvasculature triggers the tissular lesions of purpura fulminans. J. Infect. Dis. 208, 1590–1597 (2013).
Capel, E. et al. Peripheral blood vessels are a niche for blood-borne meningococci. Virulence 8, 1808–1819 (2017).
Morand, P. C. et al. Type IV pilus retraction in pathogenic Neisseria is regulated by the PilC proteins. EMBO J. 23, 2009–2017 (2004).
Juarez, O. & Barquera, B. Insights into the mechanism of electron transfer and sodium translocation of the Na(+)-pumping NADH:quinone oxidoreductase. Biochim. Biophys. Acta 1817, 1823–1832 (2012).
Jeworrek, C. et al. Effects of specific versus nonspecific ionic interactions on the structure and lateral organization of lipopolysaccharides. Biophys. J. 100, 2169–2177 (2011).
Lloret, J. et al. Ionic stress and osmotic pressure induce different alterations in the lipopolysaccharide of a Rhizobium meliloti strain. Appl. Environ. Microbiol. 61, 3701–3704 (1995).
Seebach, J. et al. Regulation of endothelial barrier function during flow-induced conversion to an arterial phenotype. Cardiovasc. Res. 75, 596–607 (2007).
Levy, S. B. & Marshall, B. Antibacterial resistance worldwide: causes, challenges and responses. Nat. Med. 10, S122–S129 (2004).
Marra, A. Targeting virulence for antibacterial chemotherapy: identifying and characterising virulence factors for lead discovery. Drugs Res. Dev. 7, 1–16 (2006).
Felise, H. B. et al. An inhibitor of Gram-negative bacterial virulence protein secretion. Cell Host Microbe 4, 325–336 (2008).
van Deuren, M. et al. Correlation between proinflammatory cytokines and antiinflammatory mediators and the severity of disease in meningococcal infections. J. Infect. Dis. 172, 433–439 (1995).
Amaral, L. et al. Phenothiazines, bacterial efflux pumps and targeting the macrophage for enhanced killing of intracellular XDRTB. In Vivo 24, 409–424 (2010).
Mazumder, R., Ganguly, K., Dastidar, S. G. & Chakrabarty, A. N. Trifluoperazine: a broad spectrum bactericide especially active on staphylococci and vibrios. Int. J. Antimicrob. Agents 18, 403–406 (2001).
Amaral, L., Engi, H., Viveiros, M. & Molnar, J. Review. Comparison of multidrug resistant efflux pumps of cancer and bacterial cells with respect to the same inhibitory agents. In Vivo 21, 237–244 (2007).
Reyes-Prieto, A., Barquera, B. & Juarez, O. Origin and evolution of the sodium -pumping NADH: ubiquinone oxidoreductase. PLoS ONE 9, e96696 (2014).
Van Dellen, K. L., Houot, L. & Watnick, P. I. Genetic analysis of Vibrio cholerae monolayer formation reveals a key role for DeltaPsi in the transition to permanent attachment. J. Bacteriol. 190, 8185–8196 (2008).
Minato, Y. et al. Roles of the sodium-translocating NADH:quinone oxidoreductase (Na+-NQR) on Vibrio cholerae metabolism, motility and osmotic stress resistance. PLoS ONE 9, e97083 (2014).
Maier, B., Koomey, M. & Sheetz, M. P. A force-dependent switch reverses Type IV pilus retraction. Proc. Natl Acad. Sci. USA 101, 10961–10966 (2004).
Clausen, M., Jakovljevic, V., Sogaard-Andersen, L. & Maier, B. High-force generation is a conserved property of Type IV pilus systems. J. Bacteriol. 191, 4633–4638 (2009).
Kurre, R. & Maier, B. Oxygen depletion triggers switching between discrete speed modes of gonococcal Type IV pili. Biophys. J. 102, 2556–2563 (2012).
Dewenter, L., Volkmann, T. E. & Maier, B. Oxygen governs gonococcal microcolony stability by enhancing the interaction force between Type IV pili. Integr. Biol. 7, 1161–1170 (2015).
Amaral, L. & Viveiros, M. Thioridazine: a non-antibiotic drug highly effective, in combination with first line anti-tuberculosis drugs, against any form of antibiotic resistance of mycobacterium tuberculosis due to its multi-mechanisms of action. Antibiotics 6, 1–14 (2017).
Bieber, D. et al. Type IV pili, transient bacterial aggregates, and virulence of enteropathogenic Escherichia coli. Science 280, 2114–2118 (1998).
Persat, A., Inclan, Y. F., Engel, J. N., Stone, H. A. & Gitai, Z. Type IV pili mechanochemically regulate virulence factors in Pseudomonas aeruginosa. Proc. Natl Acad. Sci. USA 112, 7563–7568 (2015).
Novotny, L. A. et al. Antibodies against the majority subunit of Type IV pili disperse nontypeable Haemophilus influenzae biofilms in a LuxS-dependent manner and confer therapeutic resolution of experimental otitis media. Mol. Microbiol. 96, 276–292 (2015).
Nassif, X. et al. Antigenic variation of pilin regulates adhesion of Neisseria meningitidis to human epithelial cells. Mol. Microbiol. 8, 719–725 (1993).
Pujol, C., Eugene, E., Marceau, M. & Nassif, X. The meningococcal PilT protein is required for induction of intimate attachment to epithelial cells following pilus-mediated adhesion. Proc. Natl Acad. Sci. USA 96, 4017–4022 (1999).
Geoffroy, M. C., Floquet, S., Metais, A., Nassif, X. & Pelicic, V. Large-scale analysis of the meningococcus genome by gene disruption: resistance to complement-mediated lysis. Genome Res. 13, 391–398 (2003).
Achtman, M. et al. Purification and characterization of eight class 5 outer membrane protein variants from a clone of Neisseria meningitidis serogroup A. J. Exp. Med. 168, 507–525 (1988).
Dyer, D. W., McKenna, W., Woods, J. P. & Sparling, P. F. Isolation by streptonigrin enrichment and characterization of a transferrin-specific iron uptake mutant of Neisseria meningitidis. Microb. Pathog. 3, 351–363 (1987).
Hoffmann, I., Eugene, E., Nassif, X., Couraud, P. O. & Bourdoulous, S. Activation of ErbB2 receptor tyrosine kinase supports invasion of endothelial cells by Neisseria meningitidis. J. Cell Biol. 155, 133–143 (2001).
Burrows, L. L. Pseudomonas aeruginosa twitching motility: Type IV pili in action. Annu. Rev. Microbiol. 66, 493–520 (2012).
Weksler, B., Romero, I. A. & Couraud, P. O. The hCMEC/D3 cell line as a model of the human blood brain barrier. Fluids Barriers CNS 10, 16 (2013).
Acknowledgements
We thank M. Robert-Genthon and F. Chretien for providing the P. aeruginosa PAO1 strain and brain tissues; M. Favier of the histology facility, A. Schmitt and T. Guilbert of the imaging facility, and K. Bailly and M. Andrieu of the cytometry facility of the Institut Cochin for their expert technical help. K.D. and L.LG. were supported by a doctoral fellowship from la Region Ile de France and the Fondation pour la Recherche Médicale, respectively. This work was supported by collaborative research grants from the Agence Nationale de la Recherche of France (grant no. ANR-14-IFEC14-0006) to S.B. and X.N. in the framework of the Infect-ERA joint transnational call (European funding for infectious diseases research), by the Société d’Accélération du Transfert de Technologie (grant no. ANR-10-SATT-05-01) to S.B. and by grant no. ANR-10-EQPX-04-01 to F.L.
Author information
Authors and Affiliations
Contributions
K.D. and M.L.B. conducted the in vitro experiments and the histological and immunofluorescence analysis of the skin grafts; L.L.G., J.P.B., C.F. and O.J.-L. conducted the in vivo experiments; A.G. performed the qPCR and multiplex assays; H.B.-S. and B.D. performed dSTORM analysis; A.J. and D.E. performed the whole-genome sequencing analysis of the bacterial resistant strains; P.P. provided the human skin tissues; M.C. provided bacterial mutants; N.B. and F.L. conducted the SEM assays; P.C.M. discussed the results and helped to write the manuscript; X.N. provided bacterial strains and discussed the results; and S.B. designed the experiments, supervised the project and wrote the manuscript.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Supplementary Information
Supplementary Videos, Supplementary Tables 1–4 and Supplementary Figures 1–14b.
Supplementary Video 1
Sample movie of meningococcal aggregates treated with trifluoperazine.
Supplementary Video 2
Sample movie of meningococcal aggregates treated with trifluoperazine.
Supplementary Video 3
Sample movie of gonococcal aggregates treated with trifluoperazine.
Supplementary Video 4
Sample movie of PilT meningococcal aggregates treated with trifluoperazine.
Rights and permissions
About this article
Cite this article
Denis, K., Le Bris, M., Le Guennec, L. et al. Targeting Type IV pili as an antivirulence strategy against invasive meningococcal disease. Nat Microbiol 4, 972–984 (2019). https://doi.org/10.1038/s41564-019-0395-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41564-019-0395-8
This article is cited by
-
Emergence of large-scale mechanical spiral waves in bacterial living matter
Nature Physics (2024)
-
Understanding purpura fulminans in adult patients
Intensive Care Medicine (2022)
-
Metabolic plasticity enables lifestyle transitions of Porphyromonas gingivalis
npj Biofilms and Microbiomes (2021)
-
Clinical phenotype and outcomes of pneumococcal versus meningococcal purpura fulminans: a multicenter retrospective cohort study
Critical Care (2021)
-
Anti-psychotic drugs block meningococcal virulence
Nature Microbiology (2019)